Analyst Ratings For Bristol-Myers Squibb (NYSE:BMY)
Today, Leerink Swann reiterated its Outperform rating on Bristol-Myers Squibb (NYSE:BMY) with a price target of $76.00.
Some recent analyst ratings include
- 2/6/2018-Leerink Swann Reiterated Rating of Outperform .
- 1/22/2018-BMO Capital Markets Reiterated Rating of Sell.
- 10/30/2017-SunTrust Banks Upgrade from a “Hold ” rating to a ” Buy” rating.
- 10/27/2017-Piper Jaffray Companies Reiterated Rating of Hold.
- 10/16/2017-Jefferies Group was Downgraded by analysts at Jefferies Group from a “Buy ” rating to a ” Hold” rating. They now have a $72.00 price target on the stock.
Dividend information for Bristol-Myers Squibb (NYSE:BMY)
Bristol-Myers Squibb (NYSE:BMY) pays an annual dividend of $1.60 with a yield of 2.68% and an average dividend growth of 2.70% based on a 3 Year Average..
Dividend History for Bristol-Myers Squibb (NYSE:BMY)
- On 12/7/2017 Bristol-Myers Squibb announced a quarterly dividend of $0.40 2.56% with an ex dividend date of 1/4/2018 which will be payable on 2/1/2018.
- On 9/13/2017 Bristol-Myers Squibb announced a quarterly dividend of $0.39 2.49% with an ex dividend date of 10/5/2017 which will be payable on 11/1/2017.
- On 6/13/2017 Bristol-Myers Squibb announced a quarterly dividend of $0.39 2.86% with an ex dividend date of 7/5/2017 which will be payable on 8/1/2017.
- On 3/2/2017 Bristol-Myers Squibb announced a quarterly dividend of $0.39 2.72% with an ex dividend date of 4/5/2017 which will be payable on 5/1/2017.
- On 12/8/2016 Bristol-Myers Squibb announced a quarterly dividend of $0.39 2.73% with an ex dividend date of 1/4/2017 which will be payable on 2/1/2017.
- On 8/3/2016 Bristol-Myers Squibb announced a quarterly dividend of $0.38 2.02% with an ex dividend date of 10/5/2016 which will be payable on 11/1/2016.
- On 6/7/2016 Bristol-Myers Squibb announced a quarterly dividend of $0.38 2.07% with an ex dividend date of 6/29/2016 which will be payable on 8/1/2016.
Recent Insider Trading Activity For Bristol-Myers Squibb (NYSE:BMY)
Bristol-Myers Squibb (NYSE:BMY) has insider ownership of 0.23% and institutional ownership of 69.70%.
- On 12/15/2017 Theodore R Samuels II, Director, bought 4,000 with an average share price of $62.30 per share and the total transaction amounting to $249,200.00.
- On 12/12/2017 Thomas J Jr. Lynch, EVP, sold 5,300 with an average share price of $63.24 per share and the total transaction amounting to $335,172.00.
- On 12/4/2017 Sandra Leung, EVP, sold 156,582 with an average share price of $63.37 per share and the total transaction amounting to $9,922,601.34.
- On 9/6/2017 Joseph C Caldarella, SVP, sold 9,340 with an average share price of $60.00 per share and the total transaction amounting to $560,400.00.
- On 8/2/2017 Theodore R Samuels II, Director, bought 6,000 with an average share price of $55.94 per share and the total transaction amounting to $335,640.00.
- On 4/7/2017 Lamberto Andreotti, Director, sold 34,000 with an average share price of $53.26 per share and the total transaction amounting to $1,810,840.00.
- On 3/28/2017 Lamberto Andreotti, Director, sold 34,000 with an average share price of $56.17 per share and the total transaction amounting to $1,909,780.00.
Recent Trading Activity for Bristol-Myers Squibb (NYSE:BMY)
Shares of Bristol-Myers Squibb closed the previous trading session at 59.91 down -1.05 1.72% with 58.97999954223633 shares trading hands.